Literature DB >> 26372153

Flow Test to Predict Early Hypotony and Hypertensive Phase After Ahmed Glaucoma Valve (AGV) Surgical Implantation.

Jason Cheng1, Laura Beltran-Agullo, Yvonne M Buys, Edward B Moss, Johanna Gonzalez, Graham E Trope.   

Abstract

PURPOSE: To assess the validity of a preimplantation flow test to predict early hypotony [intraocular pressure (IOP)≤5 mm Hg on 2 consecutive visits and hypertensive phase (HP) (IOP>21 mm Hg) after Ahmed Glaucoma Valve (AGV) implantation. PATIENTS AND METHODS: Prospective interventional study on patients receiving an AGV. A preimplantation flow test using a gravity-driven reservoir and an open manometer was performed on all AGVs. Opening pressure (OP) and closing pressure (CP) were defined as the pressure at which fluid was seen to flow or stop flowing through the AGV, respectively. OP and CP were measured twice per AGV. Patients were followed for 12 weeks.
RESULTS: In total, 20 eyes from 19 patients were enrolled. At 12 weeks the mean IOP decreased from 29.2±9.1 to 16.8±5.2 mm Hg (P<0.01). The mean AGV OP was 17.5±5.4 mm Hg and the mean CP was 6.7±2.3 mm Hg. Early (within 2 wk postoperative) HP occurred in 37% and hypotony in 16% of cases. An 18 mm Hg cutoff for the OP gave a sensitivity of 0.71, specificity of 0.83, positive predictive value of 0.71, and negative predictive value of 0.83 for predicting an early HP. A 7 mm Hg cutoff for the CP yielded a sensitivity of 1.0, specificity of 0.38, positive predictive value of 0.23, and negative predictive value of 1.0 for predicting hypotony.
CONCLUSIONS: Preoperative OP and CP may predict early hypotony or HP and may be used as a guide as to which AGV valves to discard before implantation surgery.

Entities:  

Mesh:

Year:  2016        PMID: 26372153     DOI: 10.1097/IJG.0000000000000318

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  2 in total

1.  Assessing risk factors for postoperative hypotony in Ahmed glaucoma valve implantation surgery.

Authors:  Ahmet Kaderli; Gülizar Demirok; Güner Üney; Mehmet Yakın; Berku Günal; Ümit Ekşioğlu
Journal:  Int Ophthalmol       Date:  2021-05-21       Impact factor: 2.031

2.  Risk factors for hypertensive phase after Ahmed glaucoma valve implantation.

Authors:  Onur Özalp; Serdar İlgüy; Eray Atalay; Tülay Şimşek; Nilgün Yıldırım
Journal:  Int Ophthalmol       Date:  2021-08-22       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.